Live Online Event

October 19-21, 2020 – Pediatric Infectious Diseases: A Primary Care and Hospitalist Approach

Title:October 19-21, 2020 – Pediatric Infectious Diseases: A Primary Care and Hospitalist Approach
Dates:October 19, 2020 7:30 am - October 21, 2020 12:50 pm
Location:Online
Schedule:7:30am-12:50pm
Course #:SEMLA-webinar-pedsid-10192020

Certifications

15 AMA PRA Category 1 Credits™

15 AAFP Credits

Course Outline

Day 1

Pediatric Immunization Update and Challenges of Vaccine Refusal.

Upon completion of this session, using information published by the CDC and AAP, the participant should be able to:GL, COMP

  1. Describe the relevant epidemiology of specific vaccine-preventable diseases.
  2. Appropriately use vaccines according to ACIP and AAP recommendations.
  3. Incorporate and apply the significant changes and updates to the current ACIP/AAP recommendations
  4. Approach the problem of vaccine refusal and provide clinical strategies to effect parental education and cooperation.

Pediatric Meningitis Revisited.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Appraise common presenting features of bacterial and viral meningitis.
  2. Determine the pathogens and develop a treatment plan concerning bacterial meningitis in children as per the Cochrane Database, systematic reviews, and AAP Guidelines.
  3. Recognize the management priorities and potential complications of bacterial meningitis.
  4. Relate the effects of immunizations practices on bacterial meningitis.

Influenza: What’s New and What You Can Do.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Identify recent changes in influenza epidemiology.
  2. Enumerate CDC recommendations and Guidelines for immunization.
  3. Appropriately prescribe antiviral prophylaxis and treatment.

Pediatric Lower Respiratory Infections.

Upon completion of this session, using the evidence-based guidelines from EBM publications, the participant should be able to: EBM, GL, COMP

  1. Integrate the association of age, seasonal, clinical presentation, and chest x-ray findings with the etiology of pediatric pneumonia.
  2. Develop a diagnostic approach to infants and children suspected to have pneumonia and discuss the treatment options and the implications of emerging bacterial resistance.
  3. Apply the American Academy of Pediatrics Guidelines to the child with bronchiolitis.

Pathogens in the News: What Do They Mean For You.

Upon completion of this session and using the guidelines from the CDC, the participant should be

able to: GL, COMP

  1. Recognize the current epidemiology of highly contagious viral or other infectious diseases that are of most immediate public health concern.
  2. Identify key clinical manifestations, as documented by the CDC guidelines, of these diseases.
  3. Plan for necessary precautions for newly identified viruses as developed and recommended by the CDC protocols and guidelines.
  4. Employ CDC recommended actions to contact Hospital, Local, State and Federal Health Officials as appropriate or mandated.

Day 2

The Age of MRSA.

Upon completion of this session and using the evidence-based guidelines from the CDC, the Pediatric Infectious Diseases Society, and EBM publications, the participant should be able to: EBM, GL, COMP

  1. Describe the emergence and development of drug resistance that led to MRSA.
  2. Discuss the prevalence differences and clinical diagnosis and treatment of community and hospital associated MRSA.
  3. Recognize the importance of accurate and timely diagnosis when confronted with the possibility of MRSA.
  4. Stratify management according to clinical scenario and severity.
  5. Apply practical and proven preventative measures to reduce the risk and incidence of MRSA.

Kawasaki Disease.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Recognize clinical/laboratory manifestations of Kawasaki
  2. Evaluate and manage patients according to AAP/AHA guidelines.
  3. Recognize the potential for coronary complications.

Cases from the Files of a Pediatric ID Consultant.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Learn from instructive pediatric infectious diseases cases and be able to construct approaches to a variety of interesting clinical challenges as presented to the ID consultant.
  2. Apply clinical pearls to clinical practice, as well at the Otolaryngology Clinical Practice and other Guidelines.

Virus X: Ubiquitous, Uncanny, Understandable.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Recognize the diverse clinical manifestations of EBV infection.
  2. Order appropriate laboratory work-up based on the situation and treatment as per the AAP Guidelines.
  3. Anticipate natural history and complications of infection.

Fever in Infants.

Upon completion of this session, using the evidence-based guidelines from EBM publications, the participant should be able to: EBM, GL, COMP

  1. Identify the common bacterial pathogens associated with fever in infants < 8 weeks of age as compared to older infants.
  2. Discuss the rationale for current diagnostic evaluation in these patients.
  3. Apply the appropriate treatment options for this patient population.

Day 3

Chief Complaint: Fever and Rash.

Upon completion of this session, the participant should be able to: COMP

  1. Recognize distinctive clinical illnesses with fever and rash.
  2. Develop an approach to clinical and laboratory diagnosis.

Serious Infections of the Head and Neck.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Differentiate the clinical appearance, diagnosis and treatment of peritonsillar, retropharyngeal and parapharyngeal space infections as per the Otolaryngology Clinic Practice Guidelines.
  2. Develop an approach to the child with red, swollen eye or cheek.

Tick-Borne Infections:  Hot Spots and Bullseyes.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Analyze the epidemiology of tick-borne infections.
  2. Recognize the clinical/laboratory manifestations.
  3. Appropriately prescribe therapy, incorporating recent IDSA guidelines.

The Child with “Too Many” Infections.

Upon completion of this session, the participant should be able to: COMP

  1. Perform an office-based evaluation of the child with frequent infections.
  2. Recognize the presentation of the most common causes of recurrent infections in childhood, decide when to consider immune deficiency states, then determine the management issues for physician providing pediatric healthcare.

Infectious Diseases Walking Through Your Office Door.

Clinical Cases will be solicited throughout the week from the participants.  These cases will be selected and managed by the presenters. Diagnoses, next steps in management and expected clinical outcomes will be discussed.  The format will include panel discussion and audience participation.

Presented By

Presenter

  • Stephen C. Eppes, M.D., F.A.A.P. (Learn More)
    Professor of Pediatrics; Vice Chair, Department of Pediatrics and Director, Pediatric Infectious Diseases, Christiana Care Health System, Wilmington, DE
  • Michael J. Muszynski, M.D., F.A.A.P. (Learn More)
    Professor Emeritus, Department of Clinical Sciences, Florida State University College of Medicine, Faculty Arnold Palmer Hospital for Children

Register

You need to buy a ticket to register for this webinar. Click here to buy a ticket.

Need help? Have a question?

mail@ams4cme.com 1-866-267-4263 Disclaimer: AMS reserves the right to cancel any conference within 6 weeks of conference date. Registrants will receive a full refund within 7 business days. AMS is not responsible for charges associated with canceled flight or hotel rooms. AMS Cancellation Policy: Due to COVID-19, American Medical Seminars has implemented a Worry-Free Cancellation policy. Register for our Live Events with the peace of mind knowing you can cancel at anytime, penalty free. If you are an international attendee and need to cancel the seminar after an Invitation Letter has been sent, there is a $150.00 cancellation fee.